Brief: Rennova Health reports Q2 loss per share $1.37 from continuing operations
15/08/2017 12:30
Aug 15 (Reuters) - Rennova Health Inc RNVA.O
* Rennova health reports second quarter 2017 financial
results
* Q2 loss per share $1.37 from continuing operations
* Q2 revenue $900,000 versus $2.6 million
* Rennova Health Inc- "this has been a challenging period
for Rennova"
* Rennova Health Inc - formed advanced molecular services
group to focus on precision medicine
* Rennova Health Inc - plan to spinoff advanced molecular
services group to shareholders by end of September as an
independent publicly traded company
* Rennova Health Inc - financial results now account for
AMSG as a discontinued operation
* Rennova Health Inc - anticipate that revenues will return
to 2015 levels within next 12 months
Source text for Eikon: ID:nMKWyrb10a
Further company coverage: RNVA.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rennova Health
See all newsBrief: Rennova Health Announces Stock Exchange Agreements With Foxo Technologies For Two Operating Subsidiaries
Brief: Foxo Technologies Enters Into Share Exchange Agreements To Acquire Healthcare Operations From Rennova Health, Inc.
Brief: Rennova Health, Inc. Announces Reverse Stock Split
Brief: Rennova Health Says Purchased, Taken Delivery Of Equipment To Provide Rapid Testing For COVID-19 At 3 Sites
Brief: Rennova Health Completes Agreement To Sell West Palm Beach-Based Clinical Laboratory